1. Home
  2. HEPS vs PCRX Comparison

HEPS vs PCRX Comparison

Compare HEPS & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D-Market Electronic Services & Trading

HEPS

D-Market Electronic Services & Trading

HOLD

Current Price

$2.68

Market Cap

1.0B

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.62

Market Cap

949.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HEPS
PCRX
Founded
2000
2006
Country
Turkey
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
949.9M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
HEPS
PCRX
Price
$2.68
$26.62
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$3.07
$30.25
AVG Volume (30 Days)
162.6K
526.8K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.19
Revenue
N/A
$541,533,000.00
Revenue This Year
$41.29
$6.78
Revenue Next Year
$27.99
$8.54
P/E Ratio
N/A
$139.89
Revenue Growth
N/A
26.04
52 Week Low
$2.15
$18.80
52 Week High
$3.30
$27.66

Technical Indicators

Market Signals
Indicator
HEPS
PCRX
Relative Strength Index (RSI) 46.14 62.48
Support Level $2.52 $22.03
Resistance Level $2.92 $26.94
Average True Range (ATR) 0.12 0.67
MACD -0.00 0.26
Stochastic Oscillator 47.75 92.48

Price Performance

Historical Comparison
HEPS
PCRX

About HEPS D-Market Electronic Services & Trading

D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. It's portfolio offers its retail customers a wide selection of merchandise including electronics and non-electronics (including books, sports, toys, kids and baby products, cosmetics, furniture, etc). The Group derives revenue from the sales of goods, marketplace revenues and other revenues.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: